Characteristics of the catecholamine and histamine receptor sites mediating accumulation of cyclic adenosine 3',5'-monophosphate in guinea pig brain.
D000225:Adenine / Q000378:metabolism; D000679:Amygdala / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism*; D001933:Brain Stem / Q000378:metabolism; D002395:Catecholamines / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000378:metabolism; D002744:Chlorpheniramine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004027:Diencephalon / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006168:Guinea Pigs; D006624:Hippocampus / Q000378:metabolism; D006632:Histamine / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D066298:In Vitro Techniques; D010761:Phosphorus Radioisotopes; D011433:Propranolol / Q000494:pharmacology; D011863:Radioimmunoassay; D011941:Receptors, Adrenergic / Q000187:drug effects; D011956:Receptors, Cell Surface; D013997:Time Factors; D014316:Tritium
D002395:Catecholamines; D006634:Histamine H1 Antagonists; D010761:Phosphorus Radioisotopes; D011941:Receptors, Adrenergic; D011956:Receptors, Cell Surface; D014316:Tritium; D002744:Chlorpheniramine; D003983:Dibenzylchlorethamine; D006632:Histamine; D011433:Propranolol; D000242:Cyclic AMP; D000225:Adenine